Guangxi Kangxiang Technology Co., Ltd. signed the "Wuxuan County Zhijia Intelligent Terminal Industrial Park Project" with the Wuxuan County People's Government on April 10, 2019, and moved from Shenzhen to Laibin City, Guangxi. It is located in Chengdong Road Industry, Wuxuan County, Laibin City with convenient transportation. In the park, the total investment of the project is about 1.25 billion yuan. The project construction is implemented in two phases: the first phase invests 400 million yuan, rents a standard plant of about 37,800 square meters, installs 4 sets of smart motherboard placement equipment, and 10 smart terminal products (including smartphones) , Tablet computers, AI robots, smart wearable products, etc.) assembly lines and other equipment, 2 LCD modules, and 20 injection molding machines. In the second phase, the investment is 850 million yuan, and the planned project land is 200 mu. It is mainly used for construction engineering investment, supporting engineering investment, equipment purchase and installation costs, land purchase costs, intangible asset costs, and enrichment of corporate liquidity. Half a year after it was successfully put into production, since the outbreak of Wuhan in the early spring of 2020, the new type of pneumonia has spread to all parts of the country at an alarming rate. In the severe situation of the current epidemic, our company responded to the call of the party and the country and took the initiative to fight. During the battle of the epidemic, after the shareholders of our company discussed and decided, the medical masks, N95, goggles and infrared thermometers urgently needed in the transformation of the production market Plan to wait for medical supplies in short supply. At present, there are 9 N95 mask production lines with a daily output of up to 800,000; 15 medical mask production lines with a daily output of 1.5 million, 5 infrared thermometer production lines with a daily output of 10,000, and will continue to invest heavily in the introduction of talent, Expand production scale and increase production capacity. Through its strong R&D strength and independent innovation, the technology remains at the leading level in the industry, and through continuous innovation and growth, it has developed safer, high-quality medical device products and created more value for the human medical and health cause.